Patent 8367065 was granted and assigned to Enzon Pharmaceuticals on February, 2013 by the United States Patent and Trademark Office.
The present invention provides single chain antibody-directed polymeric prodrugs containing multifunctional linkers. Methods of making the polymeric delivery systems and methods of treating mammals using the same are also disclosed.